您的购物车当前为空
TAK-220 is a selective and orally bioavailable CCR5 antagonist (IC50s: 3.5 nM and 1.4 nM for inhibition on the binding of RANTES and MIP-1α to CCR5, respectively).

TAK-220 is a selective and orally bioavailable CCR5 antagonist (IC50s: 3.5 nM and 1.4 nM for inhibition on the binding of RANTES and MIP-1α to CCR5, respectively).
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 2 mg | ¥ 1,820 | 5日内发货 | |
| 5 mg | ¥ 2,890 | 5日内发货 | |
| 25 mg | ¥ 9,620 | 6-8周 | |
| 50 mg | ¥ 12,500 | 6-8周 | |
| 100 mg | ¥ 17,500 | 6-8周 | |
| 1 mL x 10 mM (in DMSO) | ¥ 3,180 | 5日内发货 |
TAK-220 相关产品
| 产品描述 | TAK-220 is a selective and orally bioavailable CCR5 antagonist (IC50s: 3.5 nM and 1.4 nM for inhibition on the binding of RANTES and MIP-1α to CCR5, respectively). |
| 靶点活性 | HIV-1 (HTN):0.93 nM (EC50)(in PBMCs), HIV-1 (HNK):1.7 nM (EC50)(in PBMCs), HIV-1 (KK):1.2 nM (EC50)(in PBMCs), HIV-1 (HTN):15 nM (EC90)(in PBMCs), HIV-1 (HHA):4 nM (EC90)(in PBMCs), RANTES-CCR5:3.5 nM (in CHO cells), HIV-1 (HKW):1.7 nM (EC50)(in PBMCs), HIV-1 (HNK):28 nM (EC90)(in PBMCs), MIP-1α-CCR5:1.4 nM (in CHO cells), X4 HIV-1 (CTV):5 nM (EC90)(in PBMCs), HIV-1 (KK):12 nM (EC90)(in PBMCs), X4 HIV-1 (CTV):0.72 nM (EC50)(in PBMCs), HIV-1 (HKW):12 nM (EC90)(in PBMCs), HIV-1 (HHA):0.55 nM (EC50)(in PBMCs) |
| 体外活性 | TAK-220 inhibits R5 HIV-1 (JR-FL) envelope-mediated membrane fusion (IC50: 0.42 nM). TAK-220 shows potent inhibitory activity against the R5 isolates, with IC50s of 3.12 nM against HIV-1 R5-08, 13.47 nM against HIV-1 R5-06, and 2.26 nM against HIV-1 R5-18. TAK-220 (>100 nM) has no toxicity in uninfected PBMCs. TAK-220 (0-1000 nM) interacts with CCR5 but not with RANTES and inhibits the CCR5-mediated Casup>2+ signaling. TAK-220 also selectively inhibits HIV-1, with EC50s of 1.2 nM (HIV-1 KK), 0.72 nM (HIV-1 CTV), 1.7 nM (HIV-1 HKW), 1.7 nM (HIV-1 HNK), 0.93 nM (HIV-1 HTN), and 0.55 nM (HIV-1 HHA), and EC90s of 12 nM (HIV-1 KK), 5 nM (HIV-1 CTV), 12 nM (HIV-1 HKW), 28 nM (HIV-1 HNK), 15 nM (HIV-1 HTN), and 4 nM (HIV-1 HHA) in PBMCs [1][2]. |
| 分子量 | 553.14 |
| 分子式 | C31H41ClN4O3 |
| CAS No. | 333994-00-6 |
| 密度 | 1.208 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 50 mg/mL (90.39 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween-80+45% Saline: 2.5 mg/mL (4.52 mM), Sonication is recommeded. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||
评论内容